Skip to main content
. 2024 May 27;25(11):5825. doi: 10.3390/ijms25115825

Figure 2.

Figure 2

Pattern of recurrence among IHC subtypes. Legend: (A) Visceral recurrence; (B) Non-visceral/non-local/non-cerebral recurrence; (C) Local recurrence; (D) Cerebral recurrence. BLIS—basal-like immunosuppressed; BLIA—basal-like immunoactivated; LAR—luminal androgen receptor; MES—mesenchymal.